Table 2.
Study | Study Design | Antibiotic 1 | Surgery | Measured Antibiotic Concs (Analytical Assay) | Number of SSI Cases and Comparators or Controls 2 | Key Findings Regarding Antibiotic Concentration and SSI |
---|---|---|---|---|---|---|
Zelenitsky et al., 2002 [31] | PKPD subgroup analysis in a prospective double-blinded trial of a single-dose vs. multiple-dose regimen of gentamicin and metronidazole prophylaxis (n = 146) [32]. 3 | Gentamicin | Colorectal surgery | Total serum concs at least 30 min after the preoperative dose and postsurgery in recovery (fluorescence immunoassay) | 33 superficial SSIs and 10 deep SSI within 30 days vs. 91 without infection |
|
Zelenitsky et al., 2018 [33] | PKPD subgroup analysis in a prospective non-interventional PK study of cefazolin prophylaxis (n = 55) [34]. 6 | Cefazolin | CABG, cardiac valve repair or replacement 7 | Total and unbound plasma concs 30 min after the preoperative dose, prior to redosing, and within 15 min of wound closure (HPLC-tandem mass spectrometry) | 8 superficial SSIs within 30 days vs. 32 without infection |
|
Albacker et al., 2022 [35] | Prospective PK study of cefuroxime prophylaxis. 9 | Cefuroxime | CABG 7 | Total serum concs immediately before incision, before and 1 h after starting CPB, and before skin closure (analytical assay not described) | 14 SSIs (superficial within 30 days and deep/organ space within 90 days) vs. 64 without infection |
|
Takayama et al., 2022 [36] | Prospective PK study of cefmetazole prophylaxis. 11 | Cefmetazole | Colectomy (laparoscopic), proctectomy | Total serum concs at the time of incision, intestinal resection, redosing, and skin closure, and whole adipose tissue concs at the time of incision and skin closure (HPLC) | 7 superficial SSIs, 2 deep SSIs, and 4 organ space SSIs within 30 days vs. 92 without infection |
|
Sheikh et al., 2022 [40] | Prospective PK study of ceftriaxone prophylaxis in pediatrics (mean 6.1 years, range 2–12 years). 12 | Ceftriaxone | Pediatric clean or clean-contaminated surgery (multiple) | Total serum and whole adipose tissue concs simultaneously at the time of incision, mid surgery, and wound closure (HPLC) | 3 SSIs vs. 47 without infection (surveillance period not described) |
|
Sheikh et al., 2023 [41] | Prospective PK study of ceftriaxone prophylaxis. 14 | Ceftriaxone | Spinal surgery | Total serum and whole adipose tissue concs simultaneously at the time of incision, mid surgery, and wound closure (HPLC) | 4 SSIs vs. 46 without SSI (surveillance period not described) |
|
Byers et al., 2022 [42] | PK subgroup analysis in a retrospective study of extended courses of antimicrobial prophylaxis postsurgery (n = 184). 15 | Cefazolin | Megaprosthetic reconstruction | Whole tissue concs in cortical bone and adjacent skeletal muscle from punch biopsies collected during surgery (HPLC-tandem mass spectrometry) | 5 PJIs within 1 year vs. 5 procedure-matched controls without infection |
|
CABG is coronary artery bypass grafting, Conc is concentration, CPB is cardiopulmonary bypass, HPLC is high-performance liquid chromatography, OR is odds ratio, PJI is prosthetic joint infection, PK is pharmacokinetic, PD is pharmacodynamic, SAP is surgical antimicrobial prophylaxis, SSI is surgical site infection, vs. is versus. 1 Intravenous administration. 2 Number of cases included in the analysis of a concentration–response relationship. 3 Serum creatinine <150 umol/L for inclusion. Single-dose regimen of gentamicin 4.5 mg/kg and metronidazole 500 mg preoperatively compared to multiple-dose regimen of gentamicin 1.5 mg/kg and metronidazole 500 mg preoperatively and at 8, 16, and 24 h postsurgery. 4 Multivariable logistic regression analysis. 5 Receiver operating characteristic (ROC) curve. 6 Creatinine clearance ≥50 mL/min for inclusion. Cefazolin by protocol, i.e., 1–2 g preoperatively within 1 h, repeated every 4 h during surgery, and every 8 h for 2 days postsurgery. 7 Surgery involving cardiopulmonary bypass. 8 Classification and regression tree (CART) analysis. 9 Cefuroxime dosing described as “according to the Society of Thoracic Surgeons Practice Guideline Series”. 10 Univariate analysis,. 11 Cefmetazole by protocol, i.e., 1–2 g preoperatively within 1 h, repeated every 3 h during surgery. 12 Ceftriaxone by protocol, i.e., 75 mg/kg preoperatively to a maximum of 1 g after induction. 13 Correlation test with ceftriaxone serum and tissue concentration and patient characteristics as independent variables, and SSI as the dependent variable. Binary logistic regression analysis of associations between SSI with each individual predictable variable and various concentrations. 14 Ceftriaxone by protocol, i.e., 1 g preoperatively after induction. 15 Cefazolin by protocol, i.e., 1–3 g preoperatively within 1 h, repeated every 4 h during surgery, and for a median of 3 days postsurgery.